In brief, what’s happening at Penn—whether it’s across campus or around the world.
After a team of researchers showed that a certain enzyme’s presence in cartilage increased significantly in people with osteoarthritis, they targeted it with specially-loaded nanoparticles that stopped the disease’s progression in its tracks. The enzyme is largely overlooked when it comes to osteoarthritis, but the research shows it could be key to new, effective treatment for the disease.
FULL STORY AT Penn Medicine News →
In a new study, Penn Medicine researchers show that a new hyaluronic acid hydrogel system can reinforce and seal areas of injured cartilage.
FULL STORY AT Penn Medicine News →
APenn study finds that mailing free naloxone and other harm reduction supplies discreetly and confidentially to people’s homes is an effective yet largely underutilized strategy for increasing access to life-saving harm reduction supplies, one that policymakers should explicitly support given the urgent need.
FULL STORY AT Leonard Davis Institute →
A clinical trial is underway to test a Penn-developed compression tool called an “Oscipulse” to promote blood flow in order to prevent deep-vein thrombosis.
FULL STORY AT Penn Medicine News →
In an attempt to examine how the most recent Atlanta shooting and ongoing acts of anti-Asian violence have affected some of Penn’s medical students, the Perelman School of Medicine solicited volunteers who were willing to share how their race and ethnicity have affected different aspects of their medical education and identities.
FULL STORY AT Center for Health Equity Advancement →
The Diversity and Equity award recognizes an ISPN member who has demonstrated outstanding leadership in providing culturally-sensitive mental health services. Brawner has conducted extensive research into the factors influencing HIV and AIDS among Black residents of Philadelphia, and focuses on how mental health conditions, such as depression in Black youth, correlate with unhealthy behaviors. In her clinical work, she partners with behavioral health providers on interventions for adolescents with mental illness and works with youth affected by HIV/AIDS.
FULL STORY AT Penn Nursing News →
The Penn Nerve Center combines experts in neurosurgery, orthopaedic surgery, plastic surgery, and physical therapy to offer expert diagnosis and treatment for a range of nerve conditions including traumatic nerve injuries, nerve entrapment, nerve compression, and nerve tumors.
FULL STORY AT Penn Medicine News →
David C. Fajgenbaum, an assistant professor of translational medicine & human genetics, and director of the Center for Cytokine Storm Treatment & Laboratory at the Perelman School of Medicine, was awarded $1 million by the Parker Institute for Cancer Immunotherapy to expand the scope of the COvid19 Registry of Off-label & New Agents (CORONA) project and build out his team to accelerate treatment identification for COVID-19.
FULL STORY AT Penn Medicine News →
Genetics researcher Shelley L. Berger and cellular biologist M. Celeste Simon have been named as members of the 2021 class of fellows of the American Association for Cancer Research Academy, which recognizes and honors distinguished scientists whose major contributions have propelled significant innovation and progress against cancer.
FULL STORY AT Penn Medicine News →
With the goal of helping to improve access to dental care for individuals with disabilities, Penn Dental Medicine will be establishing a new continuing education series through the support of the Delta Dental Foundation. The gift will fund an online professional development program designed to help oral health professionals better understand and care for the disabilities community.
FULL STORY AT Penn Dental Medicine →
